Qualitative analysis of factors affecting adherence to the phenylketonuria diet in adolescents

Clinical Nurse Specialist

Volumn 27, Issue 4, 2013, Pages 205-210

  Sharman, Rachael ^a   Mulgrew, Kate ^a   Katsikitis, Mary ^a  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

adolescents; diet; phenylketonuria

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DIET THERAPY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MOTIVATION; PATIENT COMPLIANCE; PHENYLKETONURIA; PROTEIN RESTRICTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; STATISTICS;

ADOLESCENT; CHILD; DIET, PROTEIN-RESTRICTED; FEMALE; FOCUS GROUPS; HUMANS; MALE; MOTIVATION; PATIENT COMPLIANCE; PHENYLKETONURIAS; QUALITATIVE RESEARCH; QUESTIONNAIRES;

EID: 84880320527     PISSN: 08876274     EISSN: 15389782     Source Type: Journal    
DOI: 10.1097/NUR.0b013e31829555d5     Document Type: Article

References (16)

1. Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Pediatr Child Health. 2008;13:19-24
2. Rothman RL, Mulvaney S, Elasy TA, et al. Selfmanagement behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes. Pediatrics. 2008;121:912-919
3. Di Ciommo V, Forcella E, Cotugno G. Living with phenylketonuria from the point of view of children, adolescents, and young adults: A qualitative study. J Dev Behav Pediatr. 2012;33:229-235
4. Vegni E, Fiori L, Riva E, et al.How individualswith phenylketonuria experience their illness: An age-related qualitative study. Child Care Health Dev. 2009;36:539-548
5. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010; 376:1417-1427
6. Sullivan JE, Chang P. Emotional and behavioural functioning in phenylketonuria. J Pediatr Psychol. 1999;24:281-299
7. Australian Society for Inborn Errors of Metabolism. The PKU Handbook. Alexandra, Victoria: Human Genetic Society of Australia; 2005
8. Sharman R, Sullivan K, Young RM,McGill JJ. Tyrosine monitoring in children with early and continuously treated phenylketonuria: Results of an international practice survey [online]. J Inherit Metab Dis. 2010
9. Feillet F, MacDonald A, Hartung D, Burton B. Outcomes beyond phenylalanine: An international perspective. Molec Genet Metab. 2010;99(suppl):79-85
10. Giarelli E, Bernhardt BA, Mack R, Pyeritz RE. Adolescents' transition to self management of a chronic genetic disorder. Qual Health Res. 2008;18:441-457
11. Abrams AN, Hazen EP, Penson RT. Psychosocial issues in adolescents with cancer. Cancer Treat Rev. 2007;33:622-630
12. Feillet F, van Spronsen FJ, MacDonald A, et al. Challenges and pitfalls in the management of phenylketonuria. Pediatrics. 2010; 126:333-341
13. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77-101
14. Janz NK, Becker MH. The Health Belief Model: A decade later. Health Educ Q. 1984;11:1-47
15. Arnold GL, Vladutiu CJ, Orlowski CC, Blakely EM, DeLuca J. Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. J Inherit Metab Dis. 2004;27:137-143
16. Ten Hoedt AE, de Sonneville LMJ, Francios B, et al. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: A randomised, double-blind, placebocontrolled, crossover trial. J Inherit MetabDis. 2011;34:165-171